A National Academy member, Lockwood has held leadership positions at Ohio State, Yale and NYU 

TAMPA, Fla. (Feb. 20, 2014) – University of South Florida System President Judy Genshaft has named Charles Lockwood, MD, currently the dean of The Ohio State University College of Medicine and  a member of the Institute of Medicine of the National Academies, as the new senior vice president for USF Health and dean of the Morsani College of Medicine.

Dr. Lockwood will join the University of South Florida effective May 5, 2014. In addition to guiding USF Health – which encompasses the colleges of Medicine, Nursing, Public Health and Pharmacy – Dr. Lockwood will oversee patient care provided through the USF Physicians Group.

Dr. Charles Lockwood

“The University of South Florida System is thrilled to welcome an individual of Dr. Lockwood’s national standing to lead USF Health as we continue to provide leading-edge health education and care,” President Genshaft said. “Dr. Lockwood is not only an innovative medical educator, but he is an accomplished researcher and entrepreneurial thinker who will be a leader for our region, state and nation.

“There is no more important factor to the future success of our communities than providing high-quality, affordable and accessible healthcare. I am proud that USF continues to be at the forefront of finding cures, developing more effective treatments and creating new solutions to our most pressing health problems.”

Dr. Lockwood said: “The University of South Florida is a dynamic, entrepreneurial research institution where students, faculty and staff embrace novel solutions to individual health issues as well as public health problems. I look forward to working collaboratively in an atmosphere that focuses on finding new approaches to building a healthier world for all.”

At USF Health, he will lead more than 800 faculty members and nearly 500 physicians and healthcare practitioners who conducted more than 400,000 outpatient visits annually.

The USF Health Morsani College of Medicine enrolls 620 medical students and 717 medical residents in 85 programs. The colleges of Nursing, Public Health and Pharmacy, along with the schools of Biomedical Sciences and Physical Therapy & Rehabilitation Sciences in the College of Medicine, have more than 5,000 students. USF Health researchers were awarded more than $246.6 million in grants and contracts last year.

Prior to joining The Ohio State, Dr. Lockwood spent nine years as the Anita O’Keeffe Young Professor of Women’s Health and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine. Prior to his post at Yale, he served as the Stanley H. Kaplan Professor and Chair of the Department of Obstetrics and Gynecology at the New York University School of Medicine from 1995 to 2002, and as acting director of NYU’s Kaplan Comprehensive Cancer Center from 1998 to 2000. His previous appointments include the Mount Sinai School of Medicine in New York and the faculty of Tufts University.

Dr. Lockwood, 59, earned a Sc.B., magna cum laude, with distinction, from Brown University; his medical degree was obtained from the University of Pennsylvania School Of Medicine and he has a Master of Science in Health Care Management from the Harvard School of Public Health. He served his residency in obstetrics and gynecology at Pennsylvania Hospital and his fellowship in maternal-fetal medicine at the Yale-New Haven Hospital.

Dr. Lockwood is internationally known for his research expertise in obstetrics and gynecology garnering multiple awards, particularly his work in premature births. He has authored more than 270 peer-reviewed publications, 80 chapters and reviews, 141 editorials, authored or co-authored three books and edited seven textbooks. He is the recipient of multiple research grant awards from the National Institutes of Health and the March of Dimes and other foundations.  Dr. Lockwood has chaired and/or served on multiple committees of the American College of Obstetricians, the Food and Drug Administration, and is a past president of the Society for Gynecological Investigation, the largest international reproductive science organization.  He has been a tireless advocate of the training of physician scientists.

His clinical interests include the prevention of recurrent pregnancy loss, preterm delivery, and maternal thrombosis.  He has been named to the Castle & Connelly Survey, Best Doctors list for many years as well as the best doctors list of New York and Connecticut Magazines. He has been credited with leading a research team that discovered fetal fibronectin, the first biochemical predictor of prematurity. Lockwood also will relocate his research lab to USF.

Pending the recommendation of the Faculty and Chair of the Department of Obstetrics and Gynecology, Dr. Lockwood will be recommended for tenure to the USF Board of Trustees at the rank of full professor.

The University of South Florida is a high-impact, global research university dedicated to student success. USF is a Top 50 research university among both public and private institutions nationwide in total research expenditures, according to the National Science Foundation. Serving nearly 48,000 students, the USF System has an annual budget of $1.5 billion and an annual economic impact of $4.4 billion. USF is a member of the American Athletic Conference.

Reposted from USF Health News